Linda Kay Mckenzie, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 300 E Hampden Ave #202, Ob Gyn Anesthesia Pc, Englewood, CO 80113 Phone: 303-789-1940 Fax: 303-789-2132 |
Vicki Deane Beyer, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 300 E Hampden Ave, Ste 202 Ob Gyn Anesthesia Pc, Englewood, CO 80113 Phone: 303-789-1940 Fax: 303-789-2132 |
Mrs. Jennifer B De Gortari, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 501 E Hampden Ave, Englewood, CO 80113 Phone: 303-788-6749 |
Sarah Marie Oakes, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 300e Hampden Ave, Ste 202 Ob Gyn Anesthesia Pc, Englewood, CO 80113 Phone: 303-789-1940 Fax: 303-789-2132 |
Mark Verlyn Skidmore, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 300 E Hampton Ave, #202, Englewood, CO 80113 Phone: 303-789-1940 Fax: 303-789-2132 |
Sarina Cranage, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 333 W Hampden Ave, Ste 600, Englewood, CO 80110 Phone: 303-761-5646 Fax: 720-439-9500 |
News Archive
The latest advice to overweight and obese women is that they need to exercise 55 minutes a day for five days per week, as well as limiting their calorie intake.
In a pair of stories, Politico takes a look at how decisions made by governors in two very different states are playing.
In her study, Ohar looked at more than 500 men and women age 40 and older who had smoked 20 years or more. She found that a variation of the macrophage scavenger receptor gene (MSR-1) is related to the development of airways obstruction in some patients who smoke cigarettes.
In 2008, the World Health Organization announced a global effort to eradicate malaria, which kills about 800,000 people every year. As part of that goal, scientists are trying to develop new drugs that target the malaria parasite during the stage when it infects the human liver, which is crucial because some strains of malaria can lie dormant in the liver for several years before flaring up.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that in the follow-up portion of its Phase 2 clinical trial in patients with diabetic foot ulcers, the percentage of patients treated with the therapeutic dose of DSC127 with complete healing at 24 weeks following trial enrollment was 73% in the intent-to-treat population and 85% in the per-protocol population, a difference of 27 and 33 percentage points, respectively, compared with patients treated with placebo/standard of care.
› Verified 2 days ago